1. Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M et al: Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses 2015, 58 Suppl 1:1-15.
2. Aguin TJ, Sobel JD: Vulvovaginal candidiasis in pregnancy. Current infectious disease reports 2015, 17(6):462.
3. Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL: Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstetrics and gynecology 2004, 104(5 Pt 1):926-930.
4. Goncalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S: Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Critical reviews in microbiology 2016, 42(6):905-927.
5. Holland J, Young ML, Lee O, S CAC: Vulvovaginal carriage of yeasts other than Candida albicans. Sexually transmitted infections 2003, 79(3):249-250.
6. Larsen B: Vaginal flora in health and disease. Clinical obstetrics and gynecology 1993, 36(1):107-121.
7. van Schalkwyk J, Yudin MH: Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015, 37(3):266-274.
8. Greenberg RG, Benjamin DK, Jr.: Neonatal candidiasis: diagnosis, prevention, and treatment. The Journal of infection 2014, 69 Suppl 1:S19-22.
9. Kelly MS, Benjamin DK, Jr., Smith PB: The epidemiology and diagnosis of invasive candidiasis among premature infants. Clinics in perinatology 2015, 42(1):105-117, viii-ix.
10. Tragiannidis A, Tsoulas C, Groll AH: Invasive candidiasis and candidaemia in neonates and children: update on current guidelines. Mycoses 2015, 58(1):10-21.
11. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, 3rd, Horowitz B, Von Thron J et al: Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. The New England journal of medicine 2004, 351(9):876-883.
12. Fidel PL, Jr., Sobel JD: Immunopathogenesis of recurrent vulvovaginal candidiasis. Clinical microbiology reviews 1996, 9(3):335-348.
13. Sobel JD: Vulvovaginal candidosis. Lancet (London, England) 2007, 369(9577):1961-1971.
14. Leibovitz E: Strategies for the prevention of neonatal candidiasis. Pediatrics and neonatology 2012, 53(2):83-89.
15. Manzoni P, Mostert M, Jacqz-Aigrain E, Stronati M, Farina D: Candida colonization in the nursery. Jornal de pediatria 2012, 88(3):187-190.
16. Benjamin DK, Jr., Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R: Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117(1):84-92.
17. Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, Palazzi DL, Castagnola E, Halasa N, Velegraki A et al: Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. The Pediatric infectious disease journal 2012, 31(12):1252-1257.
18. Farr A, Kiss H, Holzer I, Husslein P, Hagmann M, Petricevic L: Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome. Acta obstetricia et gynecologica Scandinavica 2015, 94(9):989-996.
19. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA: Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. American journal of obstetrics and gynecology 1998, 178(2):374-380.
20. Kaufman DA: Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? Current opinion in pediatrics 2008, 20(3):332-340.
21. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ et al: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016, 62(4):e1-50.
22. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA: Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Journal of clinical microbiology 2005, 43(5):2155-2162.
23. Bitew A, Abebaw Y: Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC women's health 2018, 18(1):94.
24. Monroy-Perez E, Paniagua-Contreras GL, Rodriguez-Purata P, Vaca-Paniagua F, Vazquez-Villasenor M, Diaz-Velasquez C, Uribe-Garcia A, Vaca S: High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans. 2016, 2016:5930489.
25. Asticcioli S, Sacco L, Daturi R, Matti C, Nucleo E, Zara F, Pagani L: Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007. The new microbiologica 2009, 32(2):199-204.
26. Arendrup MC: Candida and candidaemia. Susceptibility and epidemiology. Danish medical journal 2013, 60(11):B4698.
27. Song YB, Suh MK, Ha GY, Kim H: Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis. Annals of dermatology 2015, 27(6):715-720.
28. Anderson MR, Klink K, Cohrssen A: Evaluation of vaginal complaints. Jama 2004, 291(11):1368-1379.
29. Ilkit M, Guzel AB: The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Critical reviews in microbiology 2011, 37(3):250-261.
30. Brandao LDS, Boniek D: Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil. 2018, 67(3):285-291.
31. Khan M, Ahmed J, Gul A, Ikram A, Lalani FK: Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infection and drug resistance 2018, 11:447-456.
32. Mucci MJ, Cuestas ML, Landanburu MF, Mujica MT: Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina. Revista iberoamericana de micologia 2017, 34(2):72-76.
33. Mukasa KJ, Herbert I, Daniel A, Sserunkuma KL, Joel B, Frederick B: Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda. British microbiology research journal 2015, 5(4):322-331.
34. Kennedy MA, Sobel JD: Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights. Current infectious disease reports 2010, 12(6):465-470.
35. Fan SR, Liu XP, Li JW: Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. The journal of obstetrics and gynaecology research 2008, 34(4):561-566.
36. Araj GF, Asmar RG, Avedissian AZ: Candida profiles and antifungal resistance evolution over a decade in Lebanon. Journal of infection in developing countries 2015, 9(9):997-1003.
37. Guzel AB, Aydin M, Meral M, Kalkanci A, Ilkit M: Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates. Infectious diseases in obstetrics and gynecology 2013, 2013:698736.
38. Zhai Y, Liu J, Zhou L, Ji T, Meng L, Gao Y, Liu R, Wang X, Li L, Lu B et al: Detection of Candida species in pregnant Chinese women with a molecular beacon method. Journal of medical microbiology 2018.
39. Mtibaa L, Fakhfakh N, Kallel A, Belhadj S, Belhaj Salah N, Bada N, Kallel K: Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. Journal de mycologie medicale 2017, 27(2):153-158.
40. Alfouzan W, Dhar R, Ashkanani H, Gupta M, Rachel C, Khan ZU: Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait. Journal de mycologie medicale 2015, 25(1):23-28.
41. Dharmik PG, Gomashe AV, Upadhyay VG: Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis. Journal of obstetrics and gynaecology of India 2013, 63(2):135-137.
42. Kalkanci A, Guzel AB, Khalil, II, Aydin M, Ilkit M, Kustimur S: Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Medical mycology 2012, 50(6):585-593.
43. Brandolt TM, Klafke GB, Goncalves CV, Bitencourt LR, Martinez AM, Mendes JF, Meireles MC, Xavier MO: Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2017, 48(1):145-150.
44. Sangare I, Sirima C, Bamba S, Zida A, Cisse M, Bazie WW, Sanou S, Dao B, Menan H, Guiguemde RT: Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. Journal de mycologie medicale 2018, 28(1):186-192.
45. Waggoner-Fountain LA, Walker MW, Hollis RJ, Pfaller MA, Ferguson JE, 2nd, Wenzel RP, Donowitz LG: Vertical and horizontal transmission of unique Candida species to premature newborns. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996, 22(5):803-808.
46. Savita Rathod, Vijayalakshmi S.: Prevalence of vaginitis during pregnancy and its fetomaternal outcome in the rural setup International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2016, 5(6):1823-1826.
47. Rasti S, Asadi MA, Taghriri A, Behrashi M, Mousavie G: Vaginal candidiasis complications on pregnant women. Jundishapur journal of microbiology 2014, 7(2):e10078.
48. Zhang X, Liao Q, Wang F, Li D: Association of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes. Medicine 2018, 97(34):e11891.
49. Eksi F, Gayyurhan ED, Balci I: In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method. TheScientificWorldJournal 2013, 2013:236903.
50. Badiee P, Badali H, Diba K, Ghadimi Moghadam A, Hosseininasab A, Jafarian H, Mohammadi R, Mirhendi H, Najafzadeh MJ, Shamsizadeh A et al: Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents. Current medical mycology 2016, 2(1):24-29.
51. Mokaddas EM, Al-Sweih NA, Khan ZU: Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. Journal of medical microbiology 2007, 56(Pt 2):255-259.
52. Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD: Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Frontiers in microbiology 2016, 7:2173.
53. Berkow EL, Lockhart SR: Fluconazole resistance in Candida species: a current perspective. Infection and drug resistance 2017, 10:237-245.